At Precision NextGen Oncology & Research Center, sarcoma is more than a disease we treat. It is a battle we fight alongside our patients every day.
Many sarcoma patients come to our center after exhausting other treatment options. For some, we are their last hope. Under the leadership of Dr. Kamlesh Kumar Sankhala, a nationally recognized sarcoma specialist, our team is committed to providing expert care, innovative treatment options, and compassionate support throughout every stage of a patient's cancer journey.
We understand that a cancer diagnosis brings not only physical and emotional challenges, but often significant financial burdens as well. At our center, we go above and beyond to help patients who have limited financial resources, inadequate insurance coverage, or barriers to accessing care. We work tirelessly to assist patients in obtaining life-saving chemotherapy, connecting them with financial assistance programs, and identifying clinical trial opportunities that may provide access to promising new treatments when standard options have been exhausted.
Our physician, NP, nurses, research staff, and patient advocates are dedicated to ensuring that no patient feels alone in this fight. We believe that every patient deserves access to the best possible care, regardless of their circumstances. Every day, we witness extraordinary courage, resilience, and determination from sarcoma patients and their families, and their strength inspires us to continue our mission.
When you support the Race to Cure Sarcoma, you are doing more than funding research. You are supporting patients who are searching for hope, helping families facing impossible challenges, and bringing new treatments closer to those who need them most.
Your investment is an investment in saving lives.
From all of us at Precision NextGen Oncology & Research Center, thank you for standing with sarcoma patients and their families. Together, through research, compassion, and community support, we can create a future with better treatments, greater hope, and ultimately, a cure.
Thanks to the Race to Cure Sarcoma events, SFA has invested over $20 million in sarcoma research, funding over 200 grants in 12 countries leading to close to 200 total publications, adding to the sarcoma research discourse. This has led to $26 million+ in additional funding, 10+ clinical trials with 5 additional pending, and 2 patents. Your investment in the RTCS events, is an investment in saving lives.
